You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 3, March 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

C-Reactive Protein as an Indicator of Infection Relapse in Patients With Abdominal Sepsis

Jerome J. Schentag, PharmD; David O'Keeffe; Mary Marmion; Philip B. Wels, MD

Arch Surg. 1984;119(3):300-304.


Abstract

• C-reactive protein (CRP) concentrations were monitored serially in 97 patients with abdominal sepsis to determine if differences in infection type or site would produce diagnostic or prognostic CRP level elevations. After surgery and abdominal infection, the average (± SD) CRP peak values were 21.2 ± 9.0 mg/dL. The CRP values rose markedly with infection, rose further with surgery, and subsided to less than 10 mg/dL with cure. Persistent levels of more than 10 mg/dL indicated abscess formation or continued infection. The average normal value at complete tissue healing after resolution of infection was 1.2 mg/dL, which was not different from that for healthy volunteers. Analysis suggested that CRP concentrations were not predictive of the type, site, or severity of abdominal infection; however, since persistent elevations were frequently associated with new or unresolved bacterial infection, serial determinations may be helpful in monitoring the course of disease and response to treatment.

(Arch Surg 1984;119:300-304)



Author Affiliations

From the Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo (Dr Schentag) and the Clinical Pharmacokinetics Laboratory (Dr Schentag, Mr O'Keeffe, and Ms Marmion), and Department of Surgery (Dr Wels), Millard Fillmore Hospital, Buffalo.


Footnotes

Accepted for publication Aug 15, 1983.

Reprint requests to Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, 3 Gates Circle, Buffalo, NY 14209 (Dr Schentag).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill Patients
Lobo et al.
Chest 2003;123:2043-2049.
ABSTRACT | FULL TEXT  

C-Reactive Protein—Undervalued, Underutilized
Gambino
Clin. Chem. 1997;43:2017-2018.
FULL TEXT  

C-Reactive Protein Levels Predict Postoperative Septic Complications
Mustard et al.
Arch Surg 1987;122:69-73.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.